JCR Pharmaceuticals
Signal active
Investment Firm
Overview
JCR Pharmaceuticals is a Japan-based company primarily engaged in the pharmaceutical business, as well as the medical and research equipment business. The Pharmaceutical business engages in the research, production, purchase and sale of medical drugs and pharmaceutical raw materials. The Medical and Research Equipment business engages in the purchase and sale of the medical and research equipment.
Highlights
Founded
1975
Industry
Biotechnology
Employees
251-500
Investment
1
Lead Investment
1
Exits
1
Stages
N/A
Investor Type
N/A
Location
Asia
Contact Information
Social
Profile Resume
JCR Pharmaceuticals, established in 1975 and headquartered in Asia., specializes in investments across Biotechnology, Pharmaceutical, Manufacturing. The organization boasts a portfolio of 1 investments, with an average round size of $56.0M and 1 successful exits. Their recent investments include Mycenax Biotech. The highest investment round they participated in was $672.0M. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.
Investment portfolio
JCR Pharmaceuticals has made 1 investments. Their most recent investment was on Jul 27, 2022, when Mycenax Biotech raised $56.0M.
investments
1
Diversity investments
0
Lead investments
1
Number of exits
1
Investments
1
| Annouced Date | Organization Name | Industry | Money Raised |
|---|---|---|---|
| Jul 27, 2022 | Mycenax Biotech | Biotechnology | 56.0M |
Exits
1
Funding Timeline
Funding rounds
1
Investors
1
Funds
0
Funding Rounds
1
JCR Pharmaceuticals has raised 1 rounds. Their latest funding was raised on Jul 27, 2022 from a Post-IPO Equity - Mycenax Biotech round.
| Annouced Date | Transaction Name | Number of Investors | Money Raised | Lead Investor |
|---|---|---|---|---|
| Jul 27, 2022 | Post-IPO Equity - Mycenax Biotech | - | 56.0M | - |
Investors
1
JCR Pharmaceuticals is funded by 1 investor(s). TPG Biotech Kantor is the most recent investors.
| Investor Name | Lead Investor | Funding Round | Money Raised |
|---|---|---|---|
TPG Biotech | Yes | Venture Round - JCR Pharmaceuticals | 0 |
TPG BiotechFund raised
2
Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.
| Annouced Date | Fund Name | Money Raised |
|---|---|---|
| May 10, 2013 | OTPPLESS | 1.0M |
| May 11, 2013 | OTPPLESS | 1.0M |
Invest in industries
Recent Activity
There is no recent news or activity for this profile.